Mural Oncology Plc Stock Performance
| MURA Stock | 3.44 0.20 5.49% |
Mural Oncology has a performance score of 1 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.91, which conveys possible diversification benefits within a given portfolio. Mural Oncology returns are very sensitive to returns on the market. As the market goes up or down, Mural Oncology is expected to follow. Mural Oncology plc right now secures a risk of 3.21%. Please verify Mural Oncology plc semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Mural Oncology plc will be following its current price movements.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Mural Oncology plc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Mural Oncology is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (5.49) | Five Day Return (7.28) | Year To Date Return (42.47) | Ten Year Return (9.47) | All Time Return (9.47) |
1 | Insider Trading | 09/20/2024 |
2 | Armistice Capital LLC Takes Position in Mural Oncology plc - MarketBeat | 09/27/2024 |
3 | Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 10/02/2024 |
4 | Mural Oncology to Present Clinical and Preclinical Data at the th Annual Meeting of the Society for Immunotherapy of Cancer | 10/07/2024 |
5 | Disposition of 7421 shares by Cutler Adam D. of Mural Oncology at 3.41 subject to Rule 16b-3 | 10/31/2024 |
6 | Disposition of 5069 shares by Goodman Vicki L of Mural Oncology at 3.33 subject to Rule 16b-3 | 11/07/2024 |
7 | Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline Progress | 11/13/2024 |
8 | Rodman Renshaw Initiates Coverage of Mural Oncology with Buy Recommendation - MSN | 11/22/2024 |
9 | Analysts Give Strong Buy Rating To This Undervalued Medical Stock With Up To 350 percent Of Share Price Upside | 12/02/2024 |
Mural |
Mural Oncology Relative Risk vs. Return Landscape
If you would invest 345.00 in Mural Oncology plc on September 18, 2024 and sell it today you would lose (1.00) from holding Mural Oncology plc or give up 0.29% of portfolio value over 90 days. Mural Oncology plc is currently generating 0.0442% in daily expected returns and assumes 3.2071% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Mural, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mural Oncology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mural Oncology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mural Oncology plc, and traders can use it to determine the average amount a Mural Oncology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0138
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MURA |
Estimated Market Risk
| 3.21 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 1 99% of assets perform better |
Based on monthly moving average Mural Oncology is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mural Oncology by adding it to a well-diversified portfolio.
Mural Oncology Fundamentals Growth
Mural Stock prices reflect investors' perceptions of the future prospects and financial health of Mural Oncology, and Mural Oncology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mural Stock performance.
| Return On Equity | -1.78 | ||||
| Return On Asset | -0.81 | ||||
| Current Valuation | (103.86 M) | ||||
| Shares Outstanding | 17.06 M | ||||
| Price To Book | 0.36 X | ||||
| EBITDA | (192.72 M) | ||||
| Net Income | (207.45 M) | ||||
| Total Debt | 15.01 M | ||||
| Book Value Per Share | 15.81 X | ||||
| Cash Flow From Operations | (194.25 M) | ||||
| Earnings Per Share | (9.03) X | ||||
| Market Capitalization | 62.1 M | ||||
| Total Asset | 301.75 M | ||||
| Retained Earnings | (30.86 M) | ||||
| Working Capital | 248.32 M | ||||
About Mural Oncology Performance
By analyzing Mural Oncology's fundamental ratios, stakeholders can gain valuable insights into Mural Oncology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mural Oncology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mural Oncology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.69) | (0.72) | |
| Return On Capital Employed | (0.71) | (0.75) | |
| Return On Assets | (0.69) | (0.72) | |
| Return On Equity | (0.79) | (0.75) |
Things to note about Mural Oncology plc performance evaluation
Checking the ongoing alerts about Mural Oncology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mural Oncology plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mural Oncology plc had very high historical volatility over the last 90 days | |
| Mural Oncology plc has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (207.45 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mural Oncology generates negative cash flow from operations | |
| Mural Oncology plc has a frail financial position based on the latest SEC disclosures | |
| About 69.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 |
- Analyzing Mural Oncology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mural Oncology's stock is overvalued or undervalued compared to its peers.
- Examining Mural Oncology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mural Oncology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mural Oncology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mural Oncology's stock. These opinions can provide insight into Mural Oncology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mural Stock analysis
When running Mural Oncology's price analysis, check to measure Mural Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mural Oncology is operating at the current time. Most of Mural Oncology's value examination focuses on studying past and present price action to predict the probability of Mural Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mural Oncology's price. Additionally, you may evaluate how the addition of Mural Oncology to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |